Company: CXAI
Filing Date: 2025-08-11
Form Type: S-3
Source: 0001829126-25-006018
Chunk: 56

Company: CXApp Inc.
Filing Date: 2025-08-11
Form: S-3
Chunk 56
---
’s 2023 Equity Incentive Plan (the “Incentive Plan”), having a weighted average exercise price of $1.52 per share; |
| ● | 677,435 shares of common stock issuable upon the vesting of outstanding restricted stock units under the Incentive Plan;                                                                                                     |

<div align='center'>S-18</div>

| ● | 2,110,500 shares of common stock available for future issuance under the Incentive Plan;                                  |
| ● | 10,751,862 shares of common stock issuable upon the exercise of public warrants at an exercise price of $11.50 per share; |

| ● | 10,280,000 shares of common stock issuable upon the exercise of private placement warrants at an exercise price of $11.50 per share; and |

| ● | prior to the pro forma adjustments                                                                                                                                                                                                    
 described above, 13,276,876 shares of common stock issuable in satisfaction of pre-paid purchases with an aggregate outstanding                                                                                                       
 balance of $4.52 million, which pre-paid purchases were issued to Streeterville pursuant to the Streeterville Purchase Agreement , assuming such shares are issued at the applicable floor price set forth in each pre-paid purchase, 
 subject to Streeterville’s sole discretion to take delivery of the shares in satisfaction of all or a portion of the                                                                                                                  
 outstanding balance of such pre-paid purchases.                                                                                                                                                                                       |

To the extent that any outstanding warrants or options are exercised, new options or other equity awards are issued under our equity incentive plan, or we issue additional shares in the future, there will be further dilution to new investors participating in this offering. In addition, we may choose to raise additional capital due to market conditions or strategic considerations. To the extent that additional capital is raised through the sale of securities, the issuance of those securities could result in further dilution to our stockholders.

<div align='center'>S-19

PLAN OF DISTRIBUTION</div>

We have entered into the sales
agreement, dated as of August 8, 2025, with Maxim, under which we may issue and sell shares of our common stock having an aggregate
offering price of up to $7,959,040 from time to time through Maxim acting as our sales agent. In no event will the actual number of shares
of common stock offered and sold by us pursuant to the sales agreement exceed the number of shares that we have available and authorized
for issuance under our certificate of incorporation.

The